Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
May 16, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	4,922	$971.56	813,171
May 16, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	4,669	$970.26	818,093
Dec 30, 2020	YANCOPOULOS GEORGE Director, President and Chief Scientific	Director, President and Chief Scientific	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	86,096	$483.25	822,207
May 16, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	9,501	$969.39	822,762
May 16, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	3,213	$968.44	832,263
May 01, 2012	YANCOPOULOS GEORGE Director, EVP CSO President Regeneron Re	Director, EVP CSO President Regeneron Re	Form 4	Open market or private sale of non-derivative or derivative security	12,945	$135.29	833,041
Jan 05, 2012	YANCOPOULOS GEORGE Director, EVP, CSO & Pres, REGN Res Labs	Director, EVP, CSO & Pres, REGN Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	27,713	$58.00	833,041
May 16, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	907	$967.40	835,476
May 15, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	120	$989.14	836,383
May 15, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	373	$988.36	836,503

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media